Evidence map›Paper›PMID 36553418›Full record

ReviewChildren (Basel, Switzerland)2022

Risk Factors, Clinical Consequences, Prevention, and Treatment of Childhood Obesity.

Mossad Abdelhak Shaban Mohamed, Merna Mahmoud AbouKhatwa, Abdul Aziz Saifullah, Muhammad Hareez Syahmi, Mohamed Mosaad, Mahmoud E Elrggal, Inderpal Singh Dehele, Mohamed Hassan Elnaem

Open access · goldAbstract readReview
In one paragraph

Review in Children (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 3 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 3 syntheses or guidelines pooled it, 42 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Mossad Abdelhak Shaban MohamedDepartment of Pediatrics, Faculty of Medicine, International Islamic University Malaysia, Kuantan 25200, Malaysia.
Merna Mahmoud AbouKhatwaDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, Alexandria University, Alexandria 5372066, Egypt.ORCID 0000-0003-2610-7183
Abdul Aziz SaifullahFaculty of Medicine, International Islamic University Malaysia, Kuantan 25200, Malaysia.
Muhammad Hareez SyahmiFaculty of Medicine, International Islamic University Malaysia, Kuantan 25200, Malaysia.
Mohamed MosaadFaculty of Medicine, Widad University College, Kuantan 25200, Malaysia.
Mahmoud E ElrggalCollege of Pharmacy, Umm Al-Qura University, Makkah 21955, Saudi Arabia.ORCID 0000-0002-0026-5514
Inderpal Singh DeheleSchool of Pharmacy, University of Birmingham, Birmingham B15 2TT, UK.
Mohamed Hassan ElnaemSchool of Pharmaceutical Sciences, Universiti Sains Malaysia, George Town 11800, Malaysia.ORCID 0000-0003-0873-6541
International Islamic University Malaysia · MYAlexandria University · EGUmm al-Qura University · SAUniversiti Sains Malaysia · MYUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obesity might adversely affect the health and well-being of children and their families. Childhood obesity has crucial implications for health, both during childhood and as they age. It is highly associated with many acute problems and is commonly present during childhood, making visits and hospital admissions polarized in this group of children. The problems that may affect these children can be medical, such as asthma, chronic inflammation, orthopedic abnormalities, liver disease, diabetes mellitus or dyslipidemia. Long-term consequences of cardiovascular risk factors, the persistence of obesity and premature mortality are common among adults who had obesity during their early lives. Additionally, they could also suffer from psychological issues, such as low self-esteem, which puts them at risk of a much more serious psychosocial problem that may lead to depression, as well as a disruption in educational achievements and social relationships. A healthy diet, physical activity, adequate sleep, and limited screen time are all preventive measures that should be implemented at the family and community levels, preferably through well-structured programs. Furthermore, pharmacological management of childhood obesity is limited and only used after non-pharmacological interventions have failed or in the late stages of obesity. However, recent guidelines advocate the early use of medical interventions. Approved pharmacotherapeutic options include orlistat, phentermine/topiramate combination and liraglutide. There are several other options approved primarily for other specific forms of obesity or for other indications, including setmelanotide, metformin, lisdexamfetamine, zonisamide and fluoxetine. Bariatric surgery is a safe and effective option in cases with extreme obesity and comorbidities considering the need for long-term monitoring and support for cases and their families post-surgery. This review aims to discuss and highlight the recent evidence regarding risk factors, clinical consequences, prevention, and treatment of childhood obesity.

Indexed as

childhoodobesitypreventionrisk factorstreatment

Identifiers

PMID36553418
PMCPMC9776766
OpenAlexW4312140746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.